First Time Loading...
S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 98 500 KRW -0.3% Market Closed
Updated: May 23, 2024

ST Pharm Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Net Income (Common) Peer Comparison

Comparables:
207940
P
087010
F
220100
L
141080
C
268600

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Net Income (Common)
₩22B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Net Income (Common)
₩895.3B
CAGR 3-Years
50%
CAGR 5-Years
31%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Net Income (Common)
-₩15.9B
CAGR 3-Years
5%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Net Income (Common)
-₩7.6B
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Net Income (Common)
-₩73.7B
CAGR 3-Years
-119%
CAGR 5-Years
-23%
CAGR 10-Years
-29%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Net Income (Common)
-₩75.2B
CAGR 3-Years
-56%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Net Income (Common)?
Net Income (Common)
22B KRW

Based on the financial report for Mar 31, 2024, ST Pharm Co Ltd's Net Income (Common) amounts to 22B KRW.

What is ST Pharm Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
11%

Over the last year, the Net Income (Common) growth was 11%.